DPYD

In the realm of cancer treatment, personalized medicine has emerged as a promising approach to improving patient outcomes. One crucial aspect of personalized oncology revolves around the identification of genetic variations that can influence an individual’s response to specific medications. Among these medications, 5-fluorouracil (5FU), a widely used chemotherapy drug, has gained significant attention due to its connection with the DPYD gene.